Action plan for the prevention and control of noncommunicable diseases (NCDs) in the WHO European Region

Dr Oleg Chestnov, Assistant Director-General Dr Jill Farrington, Acting Head, NCD Project Office, Moscow

Dr Gauden Galea, Director

Noncommunicable Diseases and Promoting Health through the Life-course

2

Getting to 2018

2011Political

Declaration

2014Outcome

Document

2015SDGs

2015Addis Ababa

Action Agenda

2011Moscow

Declaration

20183rd High-

level Meeting

3

Getting to 2017United Nations General Assembly Progress report on how countries have implemented the four time-bound commitments

(national targets, national NCD plan, risk factor reduction, health systems response)

United Nations Economic and Social Council Progress report on the expanded mandate of the United Nations Task Force on NCDs Self-reporting of countries on health in national SDG responses to the High-level Political

Forum

World Health Assembly Updated Appendix 3 (= best buys + good buys) Approach to measure the contribution from non-State actors to NCD targets

Organisation for Economic Co-operation and Development’s Development Assistant Committee Creditor Reporting System codes to track official development assistance for NCDs

Source: WHO. European Health for All database, 2015

Regional trends in overall premature NCD mortality are promising

4

20002001

20022003

20042005

20062007

20082009

20102011

20122013

20142015

20162017

20182019

20202021

20222023

20242025

0

100

200

300

400

500

600

700

800

900

1000

Age-standardized premature NCD death rates 30─69 and projections to 2025

European Region EU members before May 2004EU members since May 2004 Linear (EU members since May 2004)

SDR,

age

s 3

0–69

yea

rs, m

ain

NCD

, pe

r 100

000

39% reduction between 2010 and 202535% reduction between 2010 and 202540% reduction between 2010 and 202542% reduction between 2010 and 2025

5

Decline in coronary heart disease mortality: contribution of prevention and treatment

The Netherlands 1978-1985 (Bots & Grobbee)England & Wales 1981-2000 (IMPACT)

England 2000-2007 (IMPACT)Ireland 1985-2000 (IMPACT)Canada 1994-2005 (IMPACT)

USA 1980-2000 (IMPACT)USA 1980-1990 (Hunink et al)

USA 1968-1976 (Goldman et al)Scotland 2000-2010 (IMPACT)

Scotland 1975-94 (IMPACT)New Zealand 1974-1981 (Jackson et al)

New Zealand 1982-1993 (IMPACT)Finland 1982-1997 (IMPACT)

Finland 1972-1992 (Vartiainen et al)Sweden 1986-2002 (IMPACT)Iceland 1981-2006 (IMPACT)Poland 1991-2005 (IMPACT)

Czech Republic 1985-2007 (IMPACT)Slovakia 1993-2008 (IMPACT)

Italy 1980-2000 (IMPACT)Spain 1988-2005 (IMPACT)

Turkey 1995-2008 (IMPACT)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

46%42%

52%44%43%

47%43%

40%43%

40%40%

46%23%24%23%25%

37%43%

50%55%

48%47%

44%52%34%

48%48%

50%50%

54%39%

51%60%50%

72%76%

72%70%

54%52%

41%40%

51%42%

10%6%

14%8%9%

3%7%7%

18%9%

4%5%

5%5%

8%5%

9%5%

1%11%

TreatmentsRisk factorsUnknown

Developments since last European NCD Action Plan

• Regional mandate for all 4 risk factors

• Geographically dispersed office in Moscow and NCD project

• Commitments have leapt forward – surveys, action plans

• Health systems strengthening for better NCD outcomes

6

PRIORITY ACTION AREAS

Governance

Surveillance, monitoring and

evaluation, research

Prevention and health promotion

Health systems

Population-level

Fiscal and marketing policies

Salt reduction

Clean air

Active living and mobility

Product reformulation and

improvement

Individual-level

Cardio-metabolic risk assessment and

management

Early detection and effective treatment

Vaccination and communicable disease control

SUPPORTING INTERVENTIONS

Oral health and musculoskeletal

health

Mental health

Health in specific settings

Overview of European NCD Action Plan 2016–2025

PRIORITY INTERVENTIONS

7

8

Contributions of existing WHO strategies and action plans to achieving the new European NCD Action

Plan

9

THANK YOU

Thank you